177 related articles for article (PubMed ID: 28274513)
1. PCTAIRE1/CDK16/PCTK1 is overexpressed in cutaneous squamous cell carcinoma and regulates p27 stability and cell cycle.
Yanagi T; Hata H; Mizuno E; Kitamura S; Imafuku K; Nakazato S; Wang L; Nishihara H; Tanaka S; Shimizu H
J Dermatol Sci; 2017 May; 86(2):149-157. PubMed ID: 28274513
[TBL] [Abstract][Full Text] [Related]
2. PCTAIRE1 regulates p27 stability, apoptosis and tumor growth in malignant melanoma.
Yanagi T; Reed JC; Matsuzawa S
Oncoscience; 2014; 1(10):624-33. PubMed ID: 25593992
[TBL] [Abstract][Full Text] [Related]
3. PCTAIRE1 phosphorylates p27 and regulates mitosis in cancer cells.
Yanagi T; Krajewska M; Matsuzawa S; Reed JC
Cancer Res; 2014 Oct; 74(20):5795-807. PubMed ID: 25205104
[TBL] [Abstract][Full Text] [Related]
4. PCTAIRE1-knockdown sensitizes cancer cells to TNF family cytokines.
Yanagi T; Shi R; Aza-Blanc P; Reed JC; Matsuzawa S
PLoS One; 2015; 10(3):e0119404. PubMed ID: 25790448
[TBL] [Abstract][Full Text] [Related]
5. CDK16 overexpressed in non-small cell lung cancer and regulates cancer cell growth and apoptosis via a p27-dependent mechanism.
Wang H; Liu H; Min S; Shen Y; Li W; Chen Y; Wang X
Biomed Pharmacother; 2018 Jul; 103():399-405. PubMed ID: 29674275
[TBL] [Abstract][Full Text] [Related]
6. Drp1 regulates mitochondrial morphology and cell proliferation in cutaneous squamous cell carcinoma.
Kitamura S; Yanagi T; Imafuku K; Hata H; Abe R; Shimizu H
J Dermatol Sci; 2017 Dec; 88(3):298-307. PubMed ID: 28818497
[TBL] [Abstract][Full Text] [Related]
7. Lack of cyclin-dependent kinase 4 inhibits c-myc tumorigenic activities in epithelial tissues.
Miliani de Marval PL; Macias E; Rounbehler R; Sicinski P; Kiyokawa H; Johnson DG; Conti CJ; Rodriguez-Puebla ML
Mol Cell Biol; 2004 Sep; 24(17):7538-47. PubMed ID: 15314163
[TBL] [Abstract][Full Text] [Related]
8. CDK16/PCTK1/PCTAIRE1 is highly expressed in melanomas but not in melanocytic nevi or sarcomas.
Yanagi T; Imafuku K; Kitamura S; Hata H; Shimizu H
J Dermatol; 2019 Jul; 46(7):634-636. PubMed ID: 31106900
[No Abstract] [Full Text] [Related]
9. Myc inhibits p27-induced erythroid differentiation of leukemia cells by repressing erythroid master genes without reversing p27-mediated cell cycle arrest.
Acosta JC; Ferrándiz N; Bretones G; Torrano V; Blanco R; Richard C; O'Connell B; Sedivy J; Delgado MD; León J
Mol Cell Biol; 2008 Dec; 28(24):7286-95. PubMed ID: 18838534
[TBL] [Abstract][Full Text] [Related]
10. Antitumor activity of UCN-01 in carcinomas of the head and neck is associated with altered expression of cyclin D3 and p27(KIP1).
Patel V; Lahusen T; Leethanakul C; Igishi T; Kremer M; Quintanilla-Martinez L; Ensley JF; Sausville EA; Gutkind JS; Senderowicz AM
Clin Cancer Res; 2002 Nov; 8(11):3549-60. PubMed ID: 12429646
[TBL] [Abstract][Full Text] [Related]
11. Retinoic acid-mediated G1 arrest is associated with induction of p27(Kip1) and inhibition of cyclin-dependent kinase 3 in human lung squamous carcinoma CH27 cells.
Hsu SL; Hsu JW; Liu MC; Chen LY; Chang CD
Exp Cell Res; 2000 Aug; 258(2):322-31. PubMed ID: 10896783
[TBL] [Abstract][Full Text] [Related]
12. Bromodomain protein BRD4 promotes cell proliferation in skin squamous cell carcinoma.
Xiang T; Bai JY; She C; Yu DJ; Zhou XZ; Zhao TL
Cell Signal; 2018 Jan; 42():106-113. PubMed ID: 29050985
[TBL] [Abstract][Full Text] [Related]
13. Increased cdc2 and cdk2 kinase activity by retinoid X receptor gamma-mediated transcriptional down-regulation of the cyclin-dependent kinase inhibitor p21Cip1/WAF1 correlates with terminal differentiation of squamous cell carcinoma lines.
Crowe DL; Shuler CF
Cell Growth Differ; 1998 Aug; 9(8):619-27. PubMed ID: 9716179
[TBL] [Abstract][Full Text] [Related]
14. Growth arrest by the cyclin-dependent kinase inhibitor p27Kip1 is abrogated by c-Myc.
Vlach J; Hennecke S; Alevizopoulos K; Conti D; Amati B
EMBO J; 1996 Dec; 15(23):6595-604. PubMed ID: 8978686
[TBL] [Abstract][Full Text] [Related]
15. The expression pattern and functional role of REIC/Dkk-3 in the development of cutaneous squamous cell carcinoma.
Shin JM; Choi DK; Kang HY; Sohn KC; Lee Y; Kim CD; Lee JH; Park BC
J Dermatol Sci; 2016 Oct; 84(1):88-96. PubMed ID: 27354306
[TBL] [Abstract][Full Text] [Related]
16. Investigation of the cell cycle regulation of cdk3-associated kinase activity and the role of cdk3 in proliferation and transformation.
Braun K; Hölzl G; Soucek T; Geisen C; Möröy T; Hengstschläger M
Oncogene; 1998 Oct; 17(17):2259-69. PubMed ID: 9811456
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of p27Kip1 arrests neuroblastoma cell growth.
Matsuo T; Seth P; Thiele CJ
Med Pediatr Oncol; 2001 Jan; 36(1):97-9. PubMed ID: 11464914
[TBL] [Abstract][Full Text] [Related]
18. Role of c-myc regulation in Zta-mediated induction of the cyclin-dependent kinase inhibitors p21 and p27 and cell growth arrest.
Rodriguez A; Jung EJ; Yin Q; Cayrol C; Flemington EK
Virology; 2001 Jun; 284(2):159-69. PubMed ID: 11384216
[TBL] [Abstract][Full Text] [Related]
19. c-myc and skp2 coordinate p27 degradation, vascular smooth muscle proliferation, and neointima formation induced by the parathyroid hormone-related protein.
Sicari BM; Troxell R; Salim F; Tanwir M; Takane KK; Fiaschi-Taesch N
Endocrinology; 2012 Feb; 153(2):861-72. PubMed ID: 22210745
[TBL] [Abstract][Full Text] [Related]
20. c-Myc represses FOXO3a-mediated transcription of the gene encoding the p27(Kip1) cyclin dependent kinase inhibitor.
Chandramohan V; Mineva ND; Burke B; Jeay S; Wu M; Shen J; Yang W; Hann SR; Sonenshein GE
J Cell Biochem; 2008 Aug; 104(6):2091-106. PubMed ID: 18393360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
